86 results
POS AM
PPBT
Purple Biotech Ltd
28 Mar 24
Prospectus update (post-effective amendment)
4:01pm
was obtained by fraud;
the opportunity given to the defendant to bring its arguments and evidence before the court was not reasonable in the opinion
424B3
PPBT
Purple Biotech Ltd
14 Nov 23
Prospectus supplement
4:13pm
by fraud;
the opportunity given to the defendant to bring its arguments and evidence before the court was not reasonable in the opinion of the Israeli
F-1/A
swha2ab
13 Nov 23
Registration statement (foreign) (amended)
4:11pm
D
chhsl4 bva
31 Oct 23
$5.43 mm in options / securities to be acquired, sold $5.43 mm, 1 investor
4:30pm
F-1
e4svixxtdnj5mks
30 Oct 23
Registration statement (foreign)
4:30pm
6-K
EX-4.1
x0rnd4x57p6
19 Oct 23
Report of Foreign Private Issuer
10:36am
424B5
riwd0lwr6f jxiym
19 Oct 23
Prospectus supplement for primary offering
10:27am
F-3/A
7ao6x7i5
17 May 23
Shelf registration (foreign) (amended)
5:20pm
424B3
g174lg75jxf9
5 Apr 23
Prospectus supplement
5:21pm
424B3
390olkr lit
3 Apr 23
Prospectus supplement
8:57am
F-3
y9y7rcypqcqz8o
7 Dec 22
Shelf registration (foreign)
9:17pm
6-K
EX-1.1
madk9 n4ig20rc7gbg
9 Jun 21
Report of Foreign Private Issuer
5:06pm
424B5
4fitg5pdv67pybqbcsrl
9 Jun 21
Prospectus supplement for primary offering
4:54pm